Concurrent Investment Advisors LLC Purchases 2,167 Shares of Aflac Incorporated (NYSE:AFL)

Concurrent Investment Advisors LLC lifted its position in shares of Aflac Incorporated (NYSE:AFL) by 6.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 35,434 shares of the financial services provider’s stock after buying an additional 2,167 shares during the period. Concurrent Investment Advisors LLC’s holdings in Aflac were worth $3,665,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of AFL. International Assets Investment Management LLC raised its stake in shares of Aflac by 10,878.5% during the third quarter. International Assets Investment Management LLC now owns 559,903 shares of the financial services provider’s stock worth $62,597,000 after acquiring an additional 554,803 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of Aflac by 471.4% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 600,000 shares of the financial services provider’s stock valued at $67,080,000 after purchasing an additional 495,000 shares during the last quarter. Assenagon Asset Management S.A. raised its position in Aflac by 670.9% in the 4th quarter. Assenagon Asset Management S.A. now owns 556,576 shares of the financial services provider’s stock worth $57,572,000 after purchasing an additional 484,378 shares during the period. World Investment Advisors LLC purchased a new position in Aflac in the 3rd quarter worth $42,290,000. Finally, Franklin Resources Inc. lifted its stake in Aflac by 75.2% in the third quarter. Franklin Resources Inc. now owns 776,131 shares of the financial services provider’s stock worth $88,533,000 after purchasing an additional 333,083 shares during the last quarter. Institutional investors own 67.44% of the company’s stock.

Wall Street Analyst Weigh In

AFL has been the topic of a number of recent research reports. BMO Capital Markets started coverage on Aflac in a research note on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price objective on the stock. Truist Financial raised their price target on Aflac from $100.00 to $105.00 and gave the stock a “hold” rating in a research report on Friday, November 1st. StockNews.com upgraded Aflac from a “sell” rating to a “hold” rating in a research report on Friday, February 14th. JPMorgan Chase & Co. raised their target price on shares of Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a report on Tuesday, January 7th. Finally, Barclays lowered their price target on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a report on Friday, February 7th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $102.86.

Aflac Price Performance

Shares of NYSE AFL opened at $104.31 on Friday. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. Aflac Incorporated has a 1 year low of $78.60 and a 1 year high of $115.50. The company’s 50-day moving average is $104.16 and its 200 day moving average is $107.26. The stock has a market capitalization of $57.95 billion, a P/E ratio of 10.87, a P/E/G ratio of 3.30 and a beta of 0.99.

Aflac (NYSE:AFL) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. On average, sell-side analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Wednesday, February 19th will be issued a $0.58 dividend. This is an increase from Aflac’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Wednesday, February 19th. This represents a $2.32 dividend on an annualized basis and a yield of 2.22%. Aflac’s dividend payout ratio is 20.83%.

Insider Buying and Selling at Aflac

In related news, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the transaction, the executive vice president now directly owns 222,618 shares in the company, valued at $23,018,701.20. This trade represents a 10.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.90% of the company’s stock.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.